CELL CULTURE MEDIA MEDICAL

Brand Owner (click to sort) Address Description
E7 Wisconsin Alumni Research Foundation 13th Floor 614 Walnut Street Madison WI 53726 cell culture media for medical or clinical use; culture media for cultivating human and animal cells for medical or clinical use; and cell culture media for use in regenerative medical methods; cell culture media for medical and veterinary diagnostic purposes;E SEVEN;cell culture media for use in scientific research; culture media for cultivating human and animal cells for scientific research;
E8 Wisconsin Alumni Research Foundation 13th Floor 614 Walnut Street Madison WI 53726 cell culture media for medical or clinical use; culture media for cultivating human and animal cells for medical or clinical use; and cell culture media for use in regenerative medical methods; cell culture media for medical and veterinary diagnostic purposes;E EIGHT;cell culture media for use in scientific research; culture media for cultivating human and animal cells for scientific research;
GROWINK UPM-KYMMENE CORPORATION Alvar Aallon katu 1 FI-00100 Helsinki Finland Cell culture media for medical and clinical use; cells for medical or clinical use; cell growth media for growing cells for medical or clinical use; cell culture media gel with cells to be 3D printed for medical or clinical use;GROW INK;Cell culture media for scientific and research use; biochemical reagents, namely, cell culture media components, supplements, and additives for non-medical purposes; media for cell culture for use in the biotechnical industry for scientific and research purposes; cell growth media for growing cells for scientific and research use; cell culture media gel to be 3D printed for research or scientific purposes; media for cell culture for use in medical research laboratories;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides defined serum-free cell culture media useful in culturing fibroblasts, especially articular chondrocytes, that avoids problems inherent in the use of serum-containing media. The defined media comprise platelet-derived growth factor (PDGF), and chemically defined lipids, or combinations of these compounds. In another aspect, the present invention also provides tissue culture methods that comprise incubating chondrocytes in the defined serum free media. The methods enhance attachment and proliferative expansion of chondrocytes seeded at low density while maintaining their redifferentiation potential.